Abeona Therapeutics: Funicular reports 7.5% stake
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Abeona Therapeutics Inc. (ABEO) is the issuer in an amended beneficial-ownership report listing Funicular Funds, LP with 5,101,883 common shares, or 7.5% of the class. Cable Car Capital, LP, Funicular’s general partner, and Jacob Ma-Weaver, Cable Car’s managing member, may each be deemed beneficial owners of the same shares.
Each reporting person lists sole voting and dispositive power over 5,101,883 shares and zero shared power. The ownership calculation uses 68,041,223 voting shares, including 57,146,840 shares outstanding reported in Abeona’s November 9, 2026 Form 10-Q, 4,494,383 shares issued to Ellodi Pharmaceuticals under an asset purchase agreement, and 6,400,000 shares issued in a private placement, both on November 6, 2026.
Key Figures
Key Terms
beneficial ownership financial
sole voting power financial
sole dispositive power financial
asset purchase agreement financial
private placement financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How was the 7.5% ABEO ownership figure calculated?
AI-generated analysis. How Rhea-AI works. Not financial advice.